Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nano-X Imaging Ltd. (NNOX : NSDQ)

• Company Description    NANO-X IMAGING LTD is a medical imaging technology company. NANO-X IMAGING LTD is based in Neve Ilan, Israel. Number of Employees: 165

• Price / Volume Information    Yesterday's Closing Price: $3.21 Daily Weekly Monthly 20 Day Moving Average: 2,472,185 shares Shares Outstanding: 65.38 (millions) Market Capitalization: $209.88 (millions) Beta: 1.07 52 Week High: $11.00 52 Week Low: $2.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.02% -5.63% 12 Week -19.35% -21.05% Year To Date -55.42% -61.44%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OFER TECH PARK 94 SHLOMO SHMELTZER ROAD - PETACH TIKVA,L3 4970602 ISR ph: 9720337359202 fax: 972-02-544-5214 mike.cavanaugh@westwicke.com None

• General Corporate Information    Officers Erez Meltzer - Chief Executive Officer and Acting Chairman Ran Daniel - Chief Financial Officer Tamar Aharon Cohen - Executive Vice President and Chief Marketing Offic Noga Kainan - Director Dan Suesskind - Director Peer Information Nano-X Imaging Ltd. (ABMD) Nano-X Imaging Ltd. (DMDS) Nano-X Imaging Ltd. (CPWY.) Nano-X Imaging Ltd. (EQUR) Nano-X Imaging Ltd. (ECIA) Nano-X Imaging Ltd. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: M70700105 SIC: 3844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 65.38 Most Recent Split Date: (:1) Beta: 1.07 Market Capitalization: $209.88 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.86 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.34 Price/Cash Flow: - Price / Sales: 17.06 EPS Growth vs. Year Ago Period: -182.61% vs. Previous Quarter: -182.61% Sales Growth vs. Year Ago Period: 13.72% vs. Previous Quarter: 13.39% ROE 09/30/25 - -48.75 06/30/25 - -32.09 03/31/25 - -30.92 ROA 09/30/25 - -43.63 06/30/25 - -28.73 03/31/25 - -27.73 Current Ratio 09/30/25 - 4.14 06/30/25 - 4.19 03/31/25 - 5.30 Quick Ratio 09/30/25 - 3.93 06/30/25 - 4.03 03/31/25 - 5.16 Operating Margin 09/30/25 - -680.11 06/30/25 - -468.29 03/31/25 - -472.19 Net Margin 09/30/25 - -680.11 06/30/25 - -468.29 03/31/25 - -472.19 Pre-Tax Margin 09/30/25 - -454.38 06/30/25 - -469.91 03/31/25 - -475.22 Book Value 09/30/25 - 2.71 06/30/25 - 2.83 03/31/25 - 3.07 Inventory Turnover 09/30/25 - 11.94 06/30/25 - 14.64 03/31/25 - 17.70 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©